Masimo CORP 10-Q quarterly reports

Masimo Corporation reports Q1 2026 revenue of $403.6 million and continues progress toward its pending acquisition by Danaher Corporation.

Masimo Corporation reported strong growth in its continuing healthcare operations for Q3 2025, but a significant net loss driven by the sale of its non-healthcare consumer business.

Masimo Corporation reports increased revenue and gross profit in its continuing healthcare operations, while navigating a significant loss from discontinued non-healthcare business due to impairment charges and ongoing complex litigations.

Masimo Corporation announces its Q1 2025 financial results, highlighted by a revenue increase and the strategic decision to sell its non-healthcare business to HARMAN International, while also addressing a recent cybersecurity incident.

Masimo Corporation's Q3 2024 results show a slight revenue increase and a net income decrease, alongside significant management changes.

Masimo Corporation's Q2 2024 results show a revenue increase driven by healthcare growth, offset by a decline in the non-healthcare segment, with overall net income remaining relatively flat.

Masimo Corporation's first quarter 2024 results show a decrease in revenue compared to the same period last year, impacted by both healthcare and non-healthcare segment challenges.